Figure 1.
Overall survival among 348 patients older than 55 years with previously untreated AML entered onto a recent ECOG trial. Reprinted with permission from Rowe JM et al. Blood. 2004;103:479–485.7
Overall survival among 348 patients older than 55 years with previously untreated AML entered onto a recent ECOG trial. Reprinted with permission from Rowe JM et al. Blood. 2004;103:479–485.7
